Autoimmune And Inflammation Rheumatoid Arthritis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Rheumatoid Arthritis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Rheumatoid Arthritis Projects
--Active Biotech
--4SC AG
--Amgen Inc
--Aderis Pharmaceuticals, Inc.
--Biogen Idec Inc
--AstraZeneca Plc
--Eisai Co Ltd
--Bristol-Myers Squibb Company
--Genentech Inc
--Eli Lilly & Co
--GlaxoSmithKline plc
--Genmab A/S
--Merrimack Pharmaceuticals, Inc.
--Johnson & Johnson
--Pfizer Inc
--Novartis AG
--Santen Pharmaceutical Co., Ltd.
--Roche Holdings Ltd
--Wyeth
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Rheumatoid Arthritis Projects
--Advanced Viral Research Corp
--Active Biotech
--Arana Therapeutics Limited
--Amgen Inc
--Biogen Idec Inc
--AstraZeneca Plc
--Celgene Corporation
--Bone Medical Ltd
--Cytos Biotechnology AG
--ChemoCentryx, Inc.
--EntreMed Inc
--Debiopharm Group
--Neurotech Pharmaceuticals
--GlaxoSmithKline plc
--Roche Holdings Ltd
--Pfizer Inc
--Viron Therapeutics Inc
--TOYAMA CHEMICAL CO.,LTD.
--Xencor
--Wyeth

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View